Alector
ALEC----
Alector (ALEC)
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Alector Analyst Rating
View MoreForecast & Rating
Jul 6, 2026Price forecast
$3.10109.46%
Forecast & RatingHold
7analysts
- Strong buy42.86%
- Buy0.00%
- Hold28.57%
- Sell14.29%
- Strong sell14.29%
News
- Market Beat · Jul 15 at 11:40 PM
Alector (NASDAQ:ALEC) Shares Up 7.9% - Still a Buy?
- Tip Ranks · Jul 9 at 05:15 PM
Alector (ALEC) Gets a Hold from Mizuho Securities
- PUBT · Jul 8 at 03:09 PM
Alector repays USD 10.43 million Hercules loan, terminates credit agreement
- PUBT · Jun 17 at 03:06 PM
Alector shareholders ratify Ernst & Young as auditor for fiscal 2026
- Market Beat · Jun 4 at 07:50 AM
Insider Selling: Alector (NASDAQ:ALEC) Insider Sells 5,709 Shares of Stock
- benzinga_article · May 8 at 10:24 AM
Alector shares are trading lower after the company reported worse-than-expected Q1 sales results.
